Adalimumab ameliorates OVA-induced airway inflammation in mice: Role of CD4 + CD25 + FOXP3 + regulatory T-cells
- 1 September 2016
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 786, 100-108
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Neutralizing TNFα restores glucocorticoid sensitivity in a mouse model of neutrophilic airway inflammationMucosal Immunology, 2015
- A human monoclonal anti-TNF alpha antibody (adalimumab) reduces airway inflammation and ameliorates lung histology in a murine model of acute asthmaAllergologia et Immunopathologia, 2015
- Targeting TNF receptors in rheumatoid arthritisInternational Immunology, 2012
- Treatment of allergic asthma: Modulation of Th2 cells and their responsesRespiratory Research, 2011
- Regulatory T Cells More Effectively Suppress Th1-Induced Airway Inflammation Compared with Th2The Journal of Immunology, 2011
- Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseasesNature Reviews Immunology, 2010
- Inhibition of Th2 Adaptive Immune Responses and Pulmonary Inflammation by Leukocyte Ig-Like Receptor B4 on Dendritic CellsThe Journal of Immunology, 2009
- The cytokine network in asthma and chronic obstructive pulmonary diseaseJournal of Clinical Investigation, 2008
- TNF-α in asthmaCurrent Opinion in Pharmacology, 2007
- Evidence of a Role of Tumor Necrosis Factor α in Refractory AsthmaNew England Journal of Medicine, 2006